Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1989;23(5):279-82.
doi: 10.1007/BF00292404.

Kinetic analysis of the in vitro cell-killing action of neocarzinostatin

Affiliations
Comparative Study

Kinetic analysis of the in vitro cell-killing action of neocarzinostatin

S Ozawa et al. Cancer Chemother Pharmacol. 1989.

Abstract

The relationship between the drug concentration and exposure time of neocarzinostatin (NCS) for a definite cell-killing effect was kinetically analyzed, taking into consideration its loss in biological activity during incubation. Its cell-killing activity was determined by a colony-forming inhibition assay, which was conducted at room temperature (25 degrees C) for 0.5-30 min exposure and at 37 degrees C for 5 min - 96 h exposure. Drug degradation at both temperatures was also investigated by bioassay. NCS lost its biological activity much faster at 37 degrees C than at 25 degrees C and the rate of loss in activity was higher at the lower initial concentration. Thus, the initial NCS concentrations necessary for 90% cell kill corresponding to each exposure time and a drug degradation constant were applied to a mathematical equation for the cell-killing effect of cell-cycle-phase-nonspecific agents. As a result, the curves for IC90-exposure time relationships predicted from drug degradation constants for 37 degrees C and 25 degrees C were fairly well fitted to the respective experimental data. These results indicate that the cell-killing action of NCS can be expressed by this mathematical equation with scrutiny of drug degradation and is dependent on the concentration-time product (C x T).

PubMed Disclaimer

References

    1. Cancer Chemother Pharmacol. 1988;21(3):185-90 - PubMed
    1. J Pharm Sci. 1971 Jun;60(6):892-5 - PubMed
    1. Biochemistry. 1981 Sep 15;20(19):5602-8 - PubMed
    1. J Antibiot (Tokyo). 1980 Dec;33(12):1545-50 - PubMed
    1. Biochemistry. 1980 Oct 14;19(21):4786-90 - PubMed

Publication types

LinkOut - more resources